Phenylpiperazinylmethylheterocycle derivatives: Synthesis and dopamine receptor binding profiles

Archiv der Pharmazie

Volumn 337, Issue 7, 2004, Pages 383-390

  Abadi, Ashraf H ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Dopaminergic ligands; Phenylpiperazinylmethylheterocycle Derivatives

Indexed keywords

1 (1 BENZOFURAN 3 YLMETHYL) 4 (2 CHLOROPHENYL)PIPERAZINE; 1 (1 BENZOFURAN 3 YLMETHYL) 4 (2 FLUOROPHENYL)PIPERAZINE; 1 (1 BENZOFURAN 3 YLMETHYL) 4 (2 METHYLPHENYL)PIPERAZINE; 1 (1H PYRROL 2 YLMETHYL) 4 [3 (TRIFLUOROMETHYL)PHENYL]PIPERAZINE; 1 (2 CHLOROPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 1 (2 ETHOXYPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 1 (2 FLUOROPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 1 (2 METHYLPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 1 (2,3 DICHLOROPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 1 (4 FLUOROPHENYL) 4 (1H PYRROL 2 YLMETHYL)PIPERAZINE; 3 [[4 (2 CHLOROPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (2 ETHOXYPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (2 FLUOROPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (2 METHYLPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (3 TRIFLUOROMETHYLPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 3 [[4 (4 FLUOROPHENYL)PIPERAZIN 1 YL]METHYL]IMIDAZO[1,2 A]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZOFURAN DERIVATIVE; BENZOTHIOPHENE DERIVATIVE; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; HETEROCYCLIC COMPOUND; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CRICETINAE; HETEROCYCLIC COMPOUNDS, 2-RING; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PIPERAZINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4544276200     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300838     Document Type: Article

References (18)

1. J. Palermo-Neto, Psychiatr. Clin. North Am. 1997, 20, 705-721.
2. P. G. Strange, Prog. Brain Res. 1993, 99, 167-179.
3. H. H. M. Van Tol, J. R. Bunzow, H. C. Guan, R. K. Sunahara, P. Seeman, H. B. Niznik, O. Civelli, Nature 1991, 350, 610-614.
4. S. L. Smalley, J. N. Bailey, C. G. Palmer, D. P. Cantwell, J. J. McGough, M. A. Del'Homme, J. R. Asarnow, J. A. Woodward, C. Ramsey, S. F. Nelson, Mol. Psychiatry 1998, 3, 427-430.
5. F. I. Tarazi, R. J. Baldessarini, Mol. Psychiatry 1999, 4, 529-538.
6. J. J. Kulagowski, H. B. Broughton, N. R. Curtis, I. M. Mawer, M. P. Ridgill, R. Baker, F. Emms, S. B. Freedman, R. Marwood, S. Patel, S. Patel, C. I, Ragan, P. D, Lesson, J. Med. Chem. 1996, 39, 1941-1942.
7. S. Löber, H. Hübner, P Gmeiner, Bioorg. Med. Chem. Lett. 1999, 9, 97-102.
8. C. Haubmann, H. Hübner, P. Gmeiner, Bioorg. Med. Chem. Lett. 1999, 9, 1969-1972.
9. J. G. Lombardino, J. Org. Chem. 1965, 30, 2403-2407.
10. S. M. N. Efange, D. C. Mash, A. B. Khare, Q. Ouyang, J. Med. Chem. 1998, 41, 4486-4491.
11. T. N. Wheeler, (Union Carbide Corporation) U.S. Patent 4431650, 1984.
12. H. Hübner, C. Haubmann, W. Utz, P. Gmeiner, J. Med. Chem. 2000, 43, 756-762.
13. J. Kraxner, H. Hübner, P. Gmeiner, Arch. Pharm. Pharm. Med. Chem. 2000, 333, 287-292.
14. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 1951, 193, 265-275.
15. H. Hübner, J. Kraxner, P. Gmeiner, J. Med. Chem. 2000, 43, 4563-4569.
16. Y. C. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099-3108.
17. ChemSketch 5.0 freeware, Advanced Chemistry Development Inc. 90 Adelaide Street West, Suite 600 Toronto, Ontario M5H 3V9, Canada.
18. th Street, Gainesville, FLI 32601, USA.